Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease

Neuroscience Letters

Volumn 356, Issue 3, 2004, Pages 207-210

  Jollivet, Christophe ^a,b   Aubert Pouessel, Anne ^a   Clavreul, Anne ^a,b   Venier Julienne, Marie Claire ^a   Montero Menei, Claudia N ^a   Benoit, Jean Pierre ^a   Menei, Philippe ^a,b  

^a INSERM   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Drug delivery; Glial cell line derived neurotrophic factor; Microspheres; Parkinson's disease; Rat

Indexed keywords

AMPHETAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RELEASE; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0442292148     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.11.051     Document Type: Article

References (19)

1. Batchelor P.E., Porritt M.J., Martinello P., Parish C.L., Liberatore G.T., Donnan G.A., Howells D.W. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol. Cell. Neurosci. 21:2002;436-453.
2. Bjorklund A., Rosenblad C., Winkler C., Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 4:1997;186-200.
3. Cheng H., Fraidakis M., Blomback B., Lapchak P., Hoffer B., Olson L. Characterization of a fibrin glue-GDNF slow-release preparation. Cell Transplant. 7:1998;53-61.
4. Finkelstein D.I., Stanic D., Parish C.L., Tomas D., Dickson K., Horne M.K. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience. 97:2000;99-112.
5. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9:2003;589-595.
6. Gouhier C., Chalon S., Aubert-Pouessel A., Venier-Julienne M.C., Jollivet C., Benoit J.P., Guilloteau D. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease. Synapse. 44:2002;124-131.
7. Hoane M.R., Gulwadi A.G., Morrison S., Hovanesian G., Lindner M.D., Tao W. Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor. Exp. Neurol. 160:1999;235-243.
8. Jollivet C., Aubert-Pouessel A., Clavreul A., Venier M.C., Remy S., Montero-Menei C., Benoit J.P., Menei P. Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease. Biomaterials. 25:2004;933-942.
9. Kirik D., Rosenblad C., Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152:1998;259-277.
10. Kordower J.H. In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease. Ann. Neurol. 53:(Suppl. 3):2003;S120-S134.
11. Menei P., Pean J.M., Nerriere-Daguin V., Jollivet C., Brachet P., Benoit J.P. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Exp. Neurol. 161:2000;259-272.
12. Nakao N., Yokote H., Nakai K., Itakura T. Promotion of survival and regeneration of nigral dopamine neurons in a rat model of Parkinson's disease after implantation of embryonal carcinoma-derived neurons genetically engineered to produce glial cell line-derived neurotrophic factor. J. Neurosurg. 92:2000;659-670.
13. Nutt J.G., Burchiel K.J., Comella C.L., Jankovic J., Lang A.E., Laws E.R. Jr., Lozano A.M., Penn R.D., Simpson R.K. Jr., Stacy M., Wooten G.F. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 60:2003;69-73.
14. Paxinos G., Watson S. The Rat Brain in Stereotaxic Coordinates. 4th Edition:1998;Academic Press, San Diego, CA.
15. Pean J.M., Menei P., Morel O., Montero-Menei C.N., Benoit J.P. Intraseptal implantation of NGF-releasing microspheres promotes the survival of axotomized cholinergic neurons. Biomaterials. 21:2000;2097-2101.
16. Pean J.M., Venier-Julienne M.C., Boury F., Menei P., Denizot B., Benoit J.P. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J. Control. Release. 56:1998;175-187.
17. Rosenblad C., Martinez-Serrano A., Bjorklund A. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience. 82:1998;129-137.
18. Tornqvist N., Bjorklund L., Almqvist P., Wahlberg L., Stromberg I. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Exp. Neurol. 164:2000;130-138.
19. Veziers J., Lesourd M., Jollivet C., Montero-Menei C., Benoit J.P., Menei P. Analysis of brain biocompatibility of drug-releasing biodegradable microspheres by scanning and transmission electron microscopy. J. Neurosurg. 95:2001;489-494.